vs

Side-by-side financial comparison of Americas Gold & Silver Corp (USAS) and EXAGEN INC. (XGN). Click either name above to swap in a different company.

Americas Gold & Silver Corp is the larger business by last-quarter revenue ($19.1M vs $16.6M, roughly 1.1× EXAGEN INC.). EXAGEN INC. runs the higher net margin — -28.1% vs -82.3%, a 54.2% gap on every dollar of revenue. On growth, EXAGEN INC. posted the faster year-over-year revenue change (21.8% vs -28.0%). EXAGEN INC. produced more free cash flow last quarter ($-3.1M vs $-41.3M).

Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.

Exagen Inc. is a clinical diagnostics company specializing in developing, manufacturing, and commercializing proprietary testing solutions for autoimmune, rheumatic, and related chronic diseases. It mainly operates in the U.S. market, serving healthcare providers and patients to support accurate disease diagnosis and treatment monitoring.

USAS vs XGN — Head-to-Head

Bigger by revenue
USAS
USAS
1.1× larger
USAS
$19.1M
$16.6M
XGN
Growing faster (revenue YoY)
XGN
XGN
+49.8% gap
XGN
21.8%
-28.0%
USAS
Higher net margin
XGN
XGN
54.2% more per $
XGN
-28.1%
-82.3%
USAS
More free cash flow
XGN
XGN
$38.3M more FCF
XGN
$-3.1M
$-41.3M
USAS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
USAS
USAS
XGN
XGN
Revenue
$19.1M
$16.6M
Net Profit
$-15.7M
$-4.7M
Gross Margin
34.2%
55.4%
Operating Margin
-29.9%
Net Margin
-82.3%
-28.1%
Revenue YoY
-28.0%
21.8%
Net Profit YoY
2.8%
-24.2%
EPS (diluted)
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
USAS
USAS
XGN
XGN
Q4 25
$16.6M
Q3 25
$19.1M
$17.2M
Q2 25
$17.2M
Q1 25
$15.5M
Q4 24
$13.7M
Q3 24
$26.5M
$12.5M
Q2 24
$15.1M
Q1 24
$14.4M
Net Profit
USAS
USAS
XGN
XGN
Q4 25
$-4.7M
Q3 25
$-15.7M
$-7.1M
Q2 25
$-4.4M
Q1 25
$-3.8M
Q4 24
$-3.8M
Q3 24
$-16.2M
$-5.0M
Q2 24
$-3.0M
Q1 24
$-3.4M
Gross Margin
USAS
USAS
XGN
XGN
Q4 25
55.4%
Q3 25
34.2%
58.4%
Q2 25
60.4%
Q1 25
58.9%
Q4 24
62.1%
Q3 24
23.6%
55.8%
Q2 24
60.1%
Q1 24
59.6%
Operating Margin
USAS
USAS
XGN
XGN
Q4 25
-29.9%
Q3 25
-18.0%
Q2 25
-15.3%
Q1 25
-21.7%
Q4 24
-24.8%
Q3 24
-37.3%
Q2 24
-17.2%
Q1 24
-20.8%
Net Margin
USAS
USAS
XGN
XGN
Q4 25
-28.1%
Q3 25
-82.3%
-41.1%
Q2 25
-25.8%
Q1 25
-24.2%
Q4 24
-27.5%
Q3 24
-60.9%
-40.2%
Q2 24
-19.7%
Q1 24
-23.3%
EPS (diluted)
USAS
USAS
XGN
XGN
Q4 25
$-0.21
Q3 25
$-0.31
Q2 25
$-0.21
Q1 25
$-0.20
Q4 24
$-0.20
Q3 24
$-0.28
Q2 24
$-0.16
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
USAS
USAS
XGN
XGN
Cash + ST InvestmentsLiquidity on hand
$39.1M
$32.2M
Total DebtLower is stronger
$22.9M
Stockholders' EquityBook value
$50.2M
$17.4M
Total Assets
$234.7M
$58.0M
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
USAS
USAS
XGN
XGN
Q4 25
$32.2M
Q3 25
$39.1M
$35.7M
Q2 25
$30.0M
Q1 25
$11.2M
Q4 24
$22.0M
Q3 24
$22.0M
Q2 24
$24.5M
Q1 24
$27.3M
Total Debt
USAS
USAS
XGN
XGN
Q4 25
$22.9M
Q3 25
$22.9M
Q2 25
$23.0M
Q1 25
$20.9M
Q4 24
$20.2M
Q3 24
$20.3M
Q2 24
$20.3M
Q1 24
$19.5M
Stockholders' Equity
USAS
USAS
XGN
XGN
Q4 25
$17.4M
Q3 25
$50.2M
$18.1M
Q2 25
$21.0M
Q1 25
$6.4M
Q4 24
$9.5M
Q3 24
$53.1M
$12.9M
Q2 24
$17.6M
Q1 24
$20.0M
Total Assets
USAS
USAS
XGN
XGN
Q4 25
$58.0M
Q3 25
$234.7M
$62.8M
Q2 25
$58.8M
Q1 25
$40.3M
Q4 24
$44.7M
Q3 24
$43.6M
Q2 24
$49.3M
Q1 24
$50.8M
Debt / Equity
USAS
USAS
XGN
XGN
Q4 25
1.31×
Q3 25
1.26×
Q2 25
1.09×
Q1 25
3.27×
Q4 24
2.12×
Q3 24
1.57×
Q2 24
1.15×
Q1 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
USAS
USAS
XGN
XGN
Operating Cash FlowLast quarter
$-12.5M
$-3.0M
Free Cash FlowOCF − Capex
$-41.3M
$-3.1M
FCF MarginFCF / Revenue
-216.5%
-18.4%
Capex IntensityCapex / Revenue
150.8%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
USAS
USAS
XGN
XGN
Q4 25
$-3.0M
Q3 25
$-12.5M
$2.9M
Q2 25
$-2.9M
Q1 25
$-10.7M
Q4 24
$363.0K
Q3 24
$2.4M
$-2.2M
Q2 24
$-2.4M
Q1 24
$-9.0M
Free Cash Flow
USAS
USAS
XGN
XGN
Q4 25
$-3.1M
Q3 25
$-41.3M
$2.7M
Q2 25
$-3.1M
Q1 25
$-10.8M
Q4 24
$217.0K
Q3 24
$-11.2M
$-2.3M
Q2 24
$-2.6M
Q1 24
$-9.1M
FCF Margin
USAS
USAS
XGN
XGN
Q4 25
-18.4%
Q3 25
-216.5%
15.5%
Q2 25
-18.0%
Q1 25
-69.6%
Q4 24
1.6%
Q3 24
-42.2%
-18.6%
Q2 24
-17.0%
Q1 24
-63.3%
Capex Intensity
USAS
USAS
XGN
XGN
Q4 25
0.3%
Q3 25
150.8%
1.6%
Q2 25
1.2%
Q1 25
0.7%
Q4 24
1.1%
Q3 24
51.2%
1.2%
Q2 24
0.9%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

USAS
USAS

Segment breakdown not available.

XGN
XGN

Commercial$9.3M56%
Government1$4.3M26%
Client Direct Bill$2.9M18%

Related Comparisons